David P. Meeker
2021
In 2021, David P. Meeker earned a total compensation of $6.5M as Chief Executive Officer at RHYTHM PHARMACEUTICALS, a 55% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $450,954 |
|---|---|
| Option Awards | $4,204,200 |
| Salary | $630,000 |
| Stock Awards | $1,164,842 |
| Other | $8,364 |
| Total | $6,458,360 |
Meeker received $4.2M in option awards, accounting for 65% of the total pay in 2021.
Meeker also received $451K in non-equity incentive plan, $630K in salary, $1.2M in stock awards and $8.4K in other compensation.
Rankings
In 2021, David P. Meeker's compensation ranked 1,958th out of 12,415 executives tracked by ExecPay. In other words, Meeker earned more than 84.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,958 out of 12,415 | 84th |
Division Manufacturing | 741 out of 5,505 | 87th |
Major group Chemicals And Allied Products | 287 out of 2,375 | 88th |
Industry group Drugs | 246 out of 2,096 | 88th |
Industry Pharmaceutical Preparations | 161 out of 1,546 | 90th |
Source: SEC filing on April 27, 2023.
Meeker's colleagues
We found four more compensation records of executives who worked with David P. Meeker at RHYTHM PHARMACEUTICALS in 2021.
2021
Hunter Smith
RHYTHM PHARMACEUTICALS
Chief Financial Officer
2021
Yann Mazabraud
RHYTHM PHARMACEUTICALS
Executive Vice President, Head of International
2021
Jennifer Chien
RHYTHM PHARMACEUTICALS
Executive Vice President, Head of North America
2021
Joseph Shulman
RHYTHM PHARMACEUTICALS